Summary
This article discusses the use of routine genetic and platelet function testing in the setting of clopidogrel treatment, the use of pharmacogenetics to determine warfarin dosing, predictive genetic testing for statin efficacy and toxicity, cost-effectiveness, and the United States Federal Drug Administration's role in pharmacogenetic data.
- Cardiology Genomics
- © 2010 MD Conference Express